Federal Register / Vol. 72, No.
215 / Wednesday, November 7, 2007 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on October 9, 2007,
Noramco Inc., 1440 Olympic Drive,
Athens, Georgia 30601, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule I and II:
Drug
Codeine-N-Oxide (9053) ..............
Morphine-N-Oxide (9307) .............
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Opium poppy (9650) ....................
Oxymorphone (9652) ...................
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Carfentanil (9743) .........................
Fentanyl (9801) ............................
The company plans to manufacture
small quantities of the Schedule I
controlled substances for internal
testing; the Schedule II controlled
substances will be manufactured in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement Administrator,
Office of Diversion Control, Federal
Register Representative (ODL),
Washington, DC 20537, or any being
sent via express mail should be sent to
Drug Enforcement Administration,
Office of Diversion Control, Federal
Register Representative (ODL), 8701
pwalker on PROD1PC71 with NOTICES
Morrissette Drive, Springfield, Virginia
22152; and must be filed no later than
January 7, 2008.
VerDate Aug<31>2005 16:14 Nov 06, 2007 Jkt 214001
62873
Dated: October 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–21849 Filed 11–6–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 26, 2007, and
published in the Federal Register on
July 3, 2007 (72 FR 36483), Penick
Schedule Corporation, 33 Industrial Road,
Pennsville, New Jersey 08070, made
I application by renewal to the Drug
I Enforcement Administration (DEA) to
II be registered as a bulk manufacturer of
II the basic classes of controlled
II substances listed in schedule II:
II
II Drug
II
II Cocaine (9041) .............................
II Codeine (9050) .............................
Dihydrocodeine (9120) .................
II
II Oxycodone (9143) ........................
II Hydromorphone (9150) ................
II Diphenoxylate (9170) ...................
II Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
II
Morphine (9300) ...........................
II Thebaine (9333) ...........................
II
Oxymorphone (9652) ...................
The company plans to manufacture
the listed controlled substances as bulk
controlled substance intermediates for
distribution to its customers for further
manufacture or to manufacture
pharmaceutical dosage forms.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Penick Corporation to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Penick Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
PO 00000 Frm 00062 Fmt 4703 Sfmt 4703
Dated: October 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–21850 Filed 11–6–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Data Users Advisory Committee;
Establishment
In accordance with the provisions of
the Federal Advisory Committee Act,
and after consultation with the General
Services Administration, I have
determined that the establishment of a
Data Users Advisory Committee to
replace the former Business Research
Advisory Council and Labor Research
Advisory Council is in the public
interest in connection with the
performance of duties imposed on the
Schedule Department of Labor.
The Committee will advise the
II
Commissioner of Labor Statistics
II
II regarding the statistical and analytical
II work of the Bureau of Labor Statistics,
II providing perspectives on these
II programs from the points of view of data
II users from various sectors of the U.S.
II economy, including the labor, business,
II research, academic, and government
II
communities.
II The Committee will not exceed 25
members. Membership and
participation in the Committee and any
subcommittees may be from, and are
intended to be broadly representative of,
the labor, business, research, academic
and government communities in the
United States. Membership of the
Committee represents a balance in terms
of the points of view represented.
Membership will consist of an equal
number of labor and business
representatives, the total number of
which is not to exceed 16.
The Committee will function solely as
an advisory body and in compliance
with the provisions of the Federal
Advisory Committee Act. The Charter
will be filed with the Library of
Congress and the appropriate
congressional committees.
Interested persons are invited to
submit comments regarding
reestablishment of the Data Users
Advisory Committee. Such comments
should be addressed to: Michael D. Levi,
Associate Commissioner, Office of
Publications and Special Studies,
Bureau of Labor Statistics, Department
of Labor, Postal Square Building, 2
Massachusetts Avenue, NE.,
E:\FR\FM\07NON1.SGM 07NON1